Covid19

Showing NaN - NaN of 18

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Covid19 Trial in India, Ukraine, United States (Niclosamide, Placebo)

Active, not recruiting
  • Covid19
  • Birmingham, Alabama
  • +24 more
Jan 31, 2023

Covid19 Trial in Birmingham (Alvelestat, Placebo)

Completed
  • Covid19
  • Birmingham, Alabama
    UAB Lung Health Center
Dec 21, 2022

COVID19, Coronavirus, Acute Respiratory Illnesses Trial in Worldwide (Chloroquine or Hydroxychloroquine, Placebo)

Completed
  • COVID19
  • +2 more
  • Chloroquine or Hydroxychloroquine
  • Placebo
  • Abomey-Calavi, Benin
  • +24 more
Jan 10, 2023

SARS-CoV Infection, Covid19 Trial in Mexico, Puerto Rico, United States (SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination

Active, not recruiting
  • SARS-CoV Infection
  • Covid19
  • SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
  • +5 more
  • Birmingham, Alabama
  • +155 more
Dec 16, 2022

High Resolution Micro OCT Imaging

Recruiting
  • Cystic Fibrosis
  • +4 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Dec 13, 2022

    Asymptomatic SARS-CoV-2 Detection in Children

    Completed
    • Covid19
    • SARS-CoV-2
      • Birmingham, Alabama
      • +4 more
      Nov 1, 2022

      Covid19 Trial in Worldwide (LYT-100, Placebo)

      Active, not recruiting
      • Covid19
      • Birmingham, Alabama
      • +30 more
      Aug 1, 2022

      Respiratory Failure, Covid19 Trial in Birmingham (Mask with Mask Adhesive/Arm 1, Mask without Mask Adhesive / Arm 2)

      Terminated
      • Respiratory Failure
      • Covid19
      • Mask with Mask Adhesive/Arm 1
      • Mask without Mask Adhesive / Arm 2
      • Birmingham, Alabama
        Sleep Disorder Center of Alabama
      Jul 25, 2022

      Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)

      Recruiting
      • Covid19
      • theraputic heparin
      • +4 more
      • Birmingham, Alabama
      • +101 more
      Jun 28, 2022

      Acute Respiratory Distress Syndrome, Covid19 Trial in United States (Descartes 30)

      Recruiting
      • Acute Respiratory Distress Syndrome
      • Covid19
      • Descartes 30
      • Birmingham, Alabama
      • +5 more
      May 19, 2022

      COVID-19 Associated Pulmonary Aspergillosis and Other Invasive

      Recruiting
      • Covid19
      • +2 more
      • Observation to monitor patients for these infections
      • Birmingham, Alabama
        The University of Alabama at Birmingham
      Apr 21, 2022

      ARDS, Covid19, Acute Hypoxemic Respiratory Failure Trial in Birmingham (Prolonged Proned Positioning, Traditional Proning Arm)

      Completed
      • ARDS
      • +2 more
      • Prolonged Proned Positioning
      • Traditional Proning Arm
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Mar 29, 2022

      Covid19 Trial in United Kingdom (Niclosamide, Placebo, Ciclesonide)

      Recruiting
      • Covid19
      • Cambridge, Cambridgeshire, United Kingdom
      • +34 more
      Feb 20, 2022

      Covid19, Myocardial Injury Trial in Worldwide (semaglutide)

      Recruiting
      • Covid19
      • Myocardial Injury
      • São Paulo, Brazil
      • +9 more
      Jan 25, 2022

      COVID-19 Antibody Responses In Cystic Fibrosis

      Recruiting
      • Covid19
      • Cystic Fibrosis
        • Southampton, Engladn, United Kingdom
        • +10 more
        Jan 17, 2022

        Covid19 Trial in United Kingdom (Brensocatib, Placebo)

        Completed
        • Covid19
        • Aberdeen, United Kingdom
        • +15 more
        Aug 12, 2021

        COVID19 Trial in Birmingham (Tranexamic acid, Placebo oral tablet)

        Withdrawn
        • COVID19
        • Tranexamic acid
        • Placebo oral tablet
        • Birmingham, Alabama
          University of Alabama at Birmingham
        Apr 21, 2021

        Acute and Chronic Kidney Disease Incidence and Outcomes in

        Enrolling by invitation
        • Covid19
        • +4 more
          • Birmingham, Alabama
          • +11 more
          Jul 27, 2020